Tabuk continues trial phase for second production line
Tabuk Cement Company (3090.SE) announced that the trial phase for the company’s second production line is still taking place and currently expects the new line to enter commercial production in 2Q17. The trial phase continuation is due to not yet reaching the required capacity and specifications, as per the contract. Continuation of the trial phase will have no financial impact on Tabuk’s financial performance. (Tadawul) Tabuk Cement: SAR11.17 as of 28 September 2016, Rating: Sell, FV: SAR12.40 per share, MCap: USD268mn, TACCO AB / 3090.SE
This website uses cookies to make the site work, to understand if the site is working well, how it is being used, to connect to social media sites (such as Facebook and Twitter) and to collect information useful to allow us and our partners to provide you with more relevant ads . Some cookies are essential to make the site work, but you can control how we use non-essential cookies at any time by clicking the “ON/OFF” button next to each category. For more information about the cookies used on this site, see Privacy Policy.
Decide which cookies you want to allow.
Strictly Necessary
These cookies are essential in order to enable you to move around our website and use its features, such as accessing secure areas of our website. Without these cookies, any services on our Site you wish to access cannot be provided.
Analytical/performance cookies
Visitors use our website, for instance which pages you go to most often, and if you get error messages from web pages.